Fidelity Investments’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207M Buy
9,905,919
+7,038,371
+245% +$98M 0.01% 832
2025
Q4
$25.4M Buy
2,867,548
+2,861,122
+44,524% +$24.7M ﹤0.01% 1686
2025
Q3
$54K Buy
6,426
+848
+15% +$5.74K ﹤0.01% 3936
2025
Q2
$28.6K Sell
5,578
-5,164
-48% -$12.8K ﹤0.01% 4143
2025
Q1
$14.7K Buy
10,742
+1,905
+22% +$4.68K ﹤0.01% 4348
2024
Q4
$27.3K Sell
8,837
-9,370,960
-100% -$43.5M ﹤0.01% 4106
2024
Q3
$72.2M Sell
9,379,797
-29,281
-0.3% -$279K ﹤0.01% 1222
2024
Q2
$80.7M Sell
9,409,078
-82,577
-0.9% -$638K 0.01% 1136
2024
Q1
$75.4M Sell
9,491,655
-295,695
-3% -$3.17M 0.01% 1167
2023
Q4
$96.9M Sell
9,787,350
-1,858,391
-16% -$16.1M 0.01% 1028
2023
Q3
$131M Buy
11,645,741
+1,276,945
+12% +$7.79M 0.01% 859
2023
Q2
$34.4M Buy
10,368,796
+859,867
+9% +$3.09M ﹤0.01% 1416
2023
Q1
$37.6M Buy
9,508,929
+425,250
+5% +$2.47M ﹤0.01% 1363
2022
Q4
$65.9M Buy
9,083,679
+2,045,339
+29% +$14.4M 0.01% 1134
2022
Q3
$25.5M Sell
7,038,340
-593,577
-8% -$2.53M ﹤0.01% 1532
2022
Q2
$34.6M Buy
7,631,917
+755,942
+11% +$4.58M ﹤0.01% 1421
2022
Q1
$52.1M Sell
6,875,975
-306,213
-4% -$2.65M ﹤0.01% 1375
2021
Q4
$78.6M Buy
7,182,188
+930,275
+15% +$11.2M 0.01% 1214
2021
Q3
$80.8M Buy
+6,251,913
New +$74.9M 0.01% 1196

Other funds holding TNGX